Buy & Sell Automatic Data Processing Inc (ADP) – Automatic Data Processing Inc Price Today
Aura AI Summary
Key Stats
- $89.23BMarket Cap
- IndustrialsSector
- -10.38%3M Drawdown
- $90.30BEnterprise Value
- 3.05%Dividend Yield
- 50% Buy | 50% SellTrading Activity
- 61 daysTypical Hold Time
Automatic Data Processing Inc (ADP) is currently valued at a market capitalization of $89.23B, with an enterprise value of $90.30B. Over the past 52 weeks, Automatic Data Processing Inc has traded between a low of $188.79 and a high of $311.4, highlighting its annual price range. Over the past three months, Automatic Data Processing Inc has recorded a drawdown of -10.38%, reflecting recent price volatility. Automatic Data Processing Inc offers a dividend yield of 3.05%, with the most recent dividend of $1.70 paid on 12 Jun 26. On average, investors hold Automatic Data Processing Inc for approximately 61 days, indicating typical investor behavior on the platform.
About Automatic Data Processing Inc
ADP is a provider of payroll and human capital management solutions servicing the full scope of businesses from micro to global enterprises. ADP was established in 1949 and serves over 990,000 clients primarily in the United States. ADP's employer services segment offers payroll, HCM solutions, HR outsourcing, insurance and retirement services. The smaller but faster-growing PEO segment provides HR outsourcing solutions to small and midsize businesses through a co-employment model.
Most Recent News
Capital Link Shipping launches new CEO insights on tanker markets, maritime resilience, and capital markets.
Capital Link Shipping has expanded its Maritime Intelligence Hub with new executive insights from leaders at Scorpio Tankers, DHT Holdings, d’Amico International Shipping, and others. These discussions cover market trends in crude oil and product tan...

Centene offers voluntary staff buyouts amid major ACA membership drop
Centene, a major U.S. health insurer, has launched a voluntary separation program allowing eligible employees to apply for buyouts as it faces a significant decline in membership, especially in its Affordable Care Act (ACA) marketplace plans. Members...

US agency proposes broader Medicare coverage for heart valve device, boosting Edwards Lifesciences.
The US Centers for Medicare & Medicaid Services (CMS) proposed removing the coverage with evidence development (CED) requirement for Transcatheter Aortic Valve Replacement (TAVR) in patients with symptomatic severe aortic stenosis. CMS also suggested...
